WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Dermaseptin B2

Governed registry record

4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. Antitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2.

    DOI: 10.1371/journal.pone.0044351

    Source identity and connection checked by Codex (AI).

  2. Dermaseptin B2 bioactive gene's potential for anticancer and anti-proliferative effect is linked to the regulation of the BAX/BBC3/AKT pathway.

    DOI: 10.1007/s12032-024-02384-8

    Source identity and connection checked by Codex (AI).

  3. Dermaseptin DA4, although closely related to dermaseptin B2, presents chemotactic and Gram-negative selective bactericidal activities.

    DOI: 10.1111/j.1742-4658.2009.07392.x

    Source identity and connection checked by Codex (AI).

  4. Studies of the antitumor mechanism of action of dermaseptin B2, a multifunctional cationic antimicrobial peptide, reveal a partial implication of cell surface glycosaminoglycans.

    DOI: 10.1371/journal.pone.0182926

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Nasirabadi FK
  • Doosti A
  • Auvynet C
  • Joanne P
  • Bourdais J
  • Nicolas P
  • Lacombe C
  • Rosenstein Y
  • Dos Santos C
  • Hamadat S
  • Le Saux K
  • Newton C
  • Mazouni M
  • Zargarian L
  • Miro-Padovani M
  • Zadigue P
  • Delbé J
  • Hamma-Kourbali Y
  • Amiche M
  • van Zoggel H
  • Carpentier G
  • Courty J